Interventional Radiologist Near Me | Fetal Medicine

This is an ultrasound examination that is usually carried out vaginally at 6-10 weeks of pregnancy. The aims of this scan are to determine the number of embryos present and whether the pregnancy is progressing normally inside the uterus.

Who should have a Fetal Anomaly Scan and why?

All women, whatever their age, have a small chance of delivering a baby with structural abnormalities that cause physical or mental limitation. Many such abnormalities can be diagnosed and ruled out with the fetal anomaly scan.

What might be seen?

Most serious abnormalities can be detected on a scan. However, it is not possible to see all problems. Some conditions such as cerebral palsy and autism will never be seen on a scan. The quality of imaging depends on many factors, including the position of the baby and the size of the mother.

Viability Scan

This is an ultrasound examination that is usually carried out vaginally at 6-10 weeks of pregnancy. The aims of this scan are to determine the number of embryos present and whether the pregnancy is progressing normally inside the uterus. This scan is useful for women who are experiencing pain or bleeding in the pregnancy and those who have had previous miscarriages or ectopic pregnancies.

The figure on the left shows a normal pregnancy at 7 weeks of gestation. The figure on the right shows the empty sac of an anembryonic pregnancy at 7 weeks.

For endocrine problems

Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions,

For the digestive system

Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions,

For the ear, nose and oropharynx

Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions,

For the respiratory system

Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions,

Make an appointment

We will send you a confirmation within 24 hours. Emergency? Call 1-2554-2356-33

Although pulmonary medicine only began to evolve as a medical specialty in the 1950s, William Welch and William Osler founded the ‘parent’ organization of the American Thoracic Society, the National Association.